Atlas Trials

Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)

Clinical trial NCT00483496 · COMPLETED

Trial details

NCT number
NCT00483496
Sponsor
Orfagen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Solar Urticaria
Start date
2007-09-01
Primary completion
2008-04-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.